OTC Markets OTCPK - Delayed Quote USD

Candriam Eqs L Biotech C USD Cap (0P00000BOM)

915.70 -9.93 (-1.07%)
At close: September 5 at 4:00 PM EDT

Top 10 Holdings (42.04% of Total Assets)

SymbolCompany% Assets
REGN
Regeneron Pharmaceuticals, Inc. 6.76%
VRTX
Vertex Pharmaceuticals Incorporated 6.16%
AMGN
Amgen Inc. 5.71%
ALNY
Alnylam Pharmaceuticals, Inc. 4.56%
GILD
Gilead Sciences, Inc. 4.50%
MRNA
Moderna, Inc. 3.35%
BIIB
Biogen Inc. 3.15%
LLY
Eli Lilly and Company 2.74%
BMRN
BioMarin Pharmaceutical Inc. 2.65%
INSM
Insmed Incorporated 2.46%

Sector Weightings

Sector0P00000BOM
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 1.27%
Stocks 98.73%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average 0P00000BOM Category Average
Price/Earnings 0 --
Price/Book 0.22 --
Price/Sales 0.12 --
Price/Cashflow 0.05 --
Median Market Cap 20,128.08 --
3 Year Earnings Growth 0 --

Bond Holdings

Performance & Risk

YTD Return 0.00%
5y Average Return 0.00%
Rank in Category (ytd) 18
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.84
Morningstar Risk Rating

Fund Overview

Category --
Fund Family Candriam
Net Assets --
YTD Return 12.36%
Yield 0.00%
Morningstar Rating
Inception Date Mar 08, 2016

Fund Summary

Related Tickers